CXCL8 and cystic fibrosis: In a CF study looking at chronic infection and inflammation, IVA led to a reduction in sputum neutrophil elastase, interleukin (IL)-8, and IL-1β levels in the first week of treatment that was sustained for 2 years [11], as well as a reduction in blood IL-6 levels [12].